Fonds InBev-Baillet Latour décerne les prix pour la Recherche Clinique 2012

18 Avril 2012 Leuven - Le Fonds InBev-Baillet Latour décerne les prix pour la Recherche Clinique 2012 au Professeur Jean-Pascal Machiels (Université Catholique de Louvain) et au Professeur Elfride De Baere (Université de Gand).
http://www.inbevbailletlatour.com/

Universal' cancer vaccine developed

8 April 2012 source Telegraph.co.ukA vaccine that can train cancer patients' own bodies to seek out and destroy tumour cells has been developed by scientists. 
The therapy, which targets a molecule found in 90 per cent of all cancers, could provide a universal injection that allows patients' immune systems to fight off common cancers including breast and prostate cancer.
Preliminary results from early clinical trials have shown the vaccine can trigger an immune response in patients and reduce levels of disease.
The scientists behind the vaccine now hope to conduct larger trials in patients to prove it can be effective against a range of